Genelux (GNLX) Cash from Operations (2022 - 2026)

Genelux's (GNLX) quarterly Cash from Operations came in at 6059000.0 in Q1 2026, down 11.48% year-on-year from 6844869.05 in Q1 2025, and up 2.26% quarter-over-quarter from 6199000.0 in Q4 2025.

Genelux (GNLX) Cash from Operations (2022 - 2026) Analysis & Trends

Genelux's Cash from Operations history runs 5 years deep, the most recent figure standing at 6059000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 11.48% year-over-year to 6059000.0 in Q1 2026; TTM through Mar 2026 was 25892000.0, a 16.06% decrease from a year earlier, with the FY2025 full-year figure at 25268000.0, down 19.03% from the prior year.
  • Cash from Operations advanced to 6059000.0 in Q1 2026 per GNLX's latest filing, from 6199000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2825000.0 in Q1 2022 and bottomed at 7065000.0 in Q2 2025.
  • The 5-year median for Cash from Operations is 5435000.0 (2025), against an average of 4768200.0.
  • Across the five-year window, Cash from Operations slumped 355.2% in 2023 and jumped 37.74% in 2024, its largest moves.
  • Year by year, Cash from Operations stood at 1518000.0 in 2022, then plunged by 355.2% to 6910000.0 in 2023, then soared by 37.74% to 4302000.0 in 2024, then slumped by 44.1% to 6199000.0 in 2025, then climbed by 2.26% to 6059000.0 in 2026.
  • Per Business Quant, the three latest GNLX Cash from Operations figures stand at 6059000.0 (Q1 2026), 6199000.0 (Q4 2025), and 6569000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 66,290.43 Bn 66,290.15 Bn - -19.59 Mn
2 Nanobiotix 1,914.07 Bn 1,914.01 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -2.49 Mn
4 BeOne Medicines 467.97 Bn 463.18 Bn 1.35 Bn 201.34 Mn
5 Vertex Pharmaceuticals 122.73 Bn 115.48 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.82 Bn 62.82 Bn - -
8 Argenx Se 56.00 Bn 50.82 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.51 Bn 34.50 Bn 959.66 Mn 70.50 Mn
10 Genelux 128.48 Mn 128.48 Mn - -6.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.06 Mn
Mar 31, 2026 -6.06 Mn
Dec 31, 2025 -6.20 Mn
Dec 31, 2025 -6.20 Mn
Sep 30, 2025 -6.57 Mn
Sep 30, 2025 -6.57 Mn
Jun 30, 2025 -7.07 Mn
Jun 30, 2025 -7.07 Mn
Mar 31, 2025 -5.44 Mn
Mar 31, 2025 -5.44 Mn
Dec 31, 2024 -4.30 Mn
Dec 31, 2024 -4.30 Mn
Sep 30, 2024 -5.75 Mn
Sep 30, 2024 -5.75 Mn
Jun 30, 2024 -6.82 Mn
Jun 30, 2024 -6.82 Mn
Mar 31, 2024 -4.35 Mn
Mar 31, 2024 -4.35 Mn
Dec 31, 2023 -6.91 Mn
Dec 31, 2023 -6.91 Mn